SMTL ID : 7wkx.1

IL-17A in complex with the humanized antibody HB0017

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.81 Å

Oligo State

hetero-2-2-2-mer

Ligands

7 x MLA: MALONIC ACID(Non-covalent)

MLA.1: 7 residues within 4Å: Chain A: Q.39, G.44, F.45 Chain C: V.90, F.92, G.104, G.105 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:F.45 MLA.3: 8 residues within 4Å: Chain B: Q.39, G.44, F.45 Chain D: Q.43, V.90, F.92, G.104, G.105 2 PLIP interactions: 1 interactions with chain B, 1 interactions with chain D Hydrogen bonds: B:F.45, D:G.105 MLA.6: 4 residues within 4Å: Chain C: V.196, S.213, F.214, N.215 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:N.215 MLA.7: 12 residues within 4Å: Chain A: F.170, P.171, V.173, S.181, L.182, S.183 Chain C: Q.165, E.166, S.167, S.181, S.182, T.183 8 PLIP interactions: 6 interactions with chain C, 2 interactions with chain A Hydrogen bonds: C:S.167, C:S.167, C:S.181, C:S.181, C:T.183, C:T.183, A:S.181, A:S.183 MLA.8: 8 residues within 4Å: Chain C: L.42, K.44, Q.50, L.52, G.62, P.64, F.67, D.87 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:D.87 Salt bridges: C:K.44, C:R.66 MLA.10: 2 residues within 4Å: Chain E: L.72, W.86 No protein-ligand interaction detected (PLIP) MLA.11: 3 residues within 4Å: Chain F: P.122, H.124, C.125 2 PLIP interactions: 2 interactions with chain F Hydrophobic interactions: F:P.122 Salt bridges: F:H.124

4 x ACY: ACETIC ACID(Non-functional Binders)

ACY.2: 4 residues within 4Å: Chain A: H.168 Chain C: T.169, E.170, D.172 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain C Salt bridges: A:H.168 Hydrogen bonds: C:D.172 ACY.4: 6 residues within 4Å: Chain B: N.31, D.52, N.54 Chain E: P.82, S.83, V.84 2 PLIP interactions: 2 interactions with chain E Hydrogen bonds: E:S.83, E:S.83 ACY.5: 2 residues within 4Å: Chain C: R.147, E.166 2 PLIP interactions: 2 interactions with chain C Water bridges: C:V.168 Salt bridges: C:R.147 ACY.9: 5 residues within 4Å: Chain B: H.168 Chain D: T.169, E.170, D.172, T.177 3 PLIP interactions: 2 interactions with chain D, 1 interactions with chain B Hydrophobic interactions: D:D.172 Hydrogen bonds: D:E.170 Salt bridges: B:H.168

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Xu, J.G. et al., Structural and functional insights into a novel pre-clinical-stage antibody targeting IL-17A for treatment of autoimmune diseases. Int.J.Biol.Macromol. (2022)

Release Date

2022-03-23

Peptides

Heavy chain of HB0017 Fab: AB
Light chain of HB0017 Fab: CD
Interleukin-17A: EF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

E
E

F
F

Heavy chain of HB0017 Fab

Light chain of HB0017 Fab

Interleukin-17A